DCVC Opportunity Fund II GP, LLC
Follow13F filer, CIK 1668343, PALO ALTO, CA
DCVC Opportunity Fund II GP, LLC reported $81,483,428 across 2 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-15.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-25-048969
- Period
- 2025-03-31
- Reported value
- $81.5M
- Holdings
- 2
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Holdings, Q1 2025
Share positions as resolved from 13F-HR 0001104659-25-048969, largest first. % of portfolio is the value over $81,483,428, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ROCKET LAB USA INCROCKET LAB USA INC | 3,388,249 | $60.6M | 74.35% | 0 | |||
| RXRXRECURSION PHARMACEUTICALS IN | 3,951,141 | $20.9M | 25.65% | 0 | Timeline |
How Q1 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001104659-25-048969 | base | 2025-05-15 | acceptance time not in the bulk data set |